ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,873Medicare Part D Prescriptions Filled, Including Refills

Rank: 154 out of 761

$438K Total Retail Price of All Prescriptions

Rank: 173 out of 761

405 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 405 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

11% of this provider’s 405 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

5% of this provider’s 7,375 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LEVOTHYROXINE SODIUM 409 373 1 3
ATENOLOL 352 329 2 8
SIMVASTATIN 305 290 3 2
FUROSEMIDE 283 248 4 7
OMEPRAZOLE 271 225 5 4
LISINOPRIL 255 244 6 1
METFORMIN HCL 207 183 7 10
CARISOPRODOL 202 124 R 8 131
GABAPENTIN 187 113 9 15
LOVASTATIN 171 166 10 17
WARFARIN SODIUM 167 142 11 9
HYDROCODONE-ACETAMINOPHEN 164 121 S3 12 5
POTASSIUM CHLORIDE 154 123 13 18
AMLODIPINE BESYLATE 127 118 14 6
TAMSULOSIN HCL 124 124 15 27
PIROXICAM 120 87 16 263
HYDROCHLOROTHIAZIDE 118 104 17 11
ZOLPIDEM TARTRATE 117 100 18 22
ATORVASTATIN CALCIUM 104 94 19 12
ALLOPURINOL 103 90 20 28
GEMFIBROZIL 100 69 21 116
CLONIDINE HCL 97 82 22 69
ENALAPRIL MALEATE 90 84 23 71
AMITRIPTYLINE HCL 89 70 R 24 54
TRAMADOL HCL 89 41 24 34
PAROXETINE HCL 84 67 26 47
ALENDRONATE SODIUM 81 75 27 21
NAMENDA 77 77 28 59
PRAVASTATIN SODIUM 77 76 28 20
METOPROLOL TARTRATE 75 58 30 14
FINASTERIDE 70 70 31 73
METOPROLOL SUCCINATE 66 66 32 16
SPIRONOLACTONE 63 57 33 45
LOSARTAN POTASSIUM 63 59 33 13
NIFEDIAC CC 61 58 35 207
DONEPEZIL HCL 59 59 36 33
CALCITONIN-SALMON 58 51 37 233
GLYBURIDE 56 52 R 38 77
AMOXICILLIN 55 48 39 200
TRAZODONE HCL 54 43 40 23
PROPRANOLOL HCL 53 42 41 100
CARVEDILOL 53 53 41 26
SERTRALINE HCL 51 51 43 25
CITALOPRAM HBR 50 41 44 19
IBUPROFEN 50 35 44 103
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 16, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.